Neostigmine Methyl Sulfate used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is sold under the brand name Prostigmin. Reference standards of Neostigmine Methyl Sulfate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Neostigmine Methyl Sulfate - API Standards [catalogue_number] => PA 14 69000 [category_ids] => ,79,78,70,82,88, [chemical_name] => [weight] => 334.39 [form] => C13H22N2O6S [cas] => 51-60-5 [pslug] => 51-60-5-neostigmine-methyl-sulfate-api-pa1469000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 41016 [offers_product_code] => PA 14 69000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 14 69000
CAS :
Molecular Formula : C13H22N2O6S
Molecular Weight : 334.39
stdClass Object ( [pname] => Neostigmine Methyl Sulfate - Impurity A [catalogue_number] => PA 14 69010 [category_ids] => ,70,78,79,82,88, [chemical_name] => [weight] => 263.31 [form] => C10H17NO5S [cas] => 4312-54-3 [pslug] => 4312-54-3-neostigmine-methyl-sulfate-impurity-a-pa1469010 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 41017 [offers_product_code] => PA 14 69010 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 14 69010
Molecular Formula : C10H17NO5S
Molecular Weight : 263.31
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
